English
 
Help Privacy Policy Disclaimer
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT
  Assessment of the protective effect of L-Carnitine in Hepatic Encephalopathy: Improvements of muscle and brain mitochondrial and fatty acid metabolism

Zwingmann, C., Gottschalk, S., Wenlei, J., Butterworth, R., & Leibfritz, D. (2007). Assessment of the protective effect of L-Carnitine in Hepatic Encephalopathy: Improvements of muscle and brain mitochondrial and fatty acid metabolism. Poster presented at 2007 Joint Annual Meeting ISMRM-ESMRMB, Berlin, Germany.

Item is

Files

show Files

Locators

show
hide
Description:
-

Creators

show
hide
 Creators:
Zwingmann, C, Author
Gottschalk, S1, Author              
Wenlei , J, Author
Butterworth, R, Author
Leibfritz, D, Author
Affiliations:
1External Organizations, ou_persistent22              

Content

show
hide
Free keywords: -
 Abstract: Hepatic Encephalopathy (HE) in both chronic and acute liver failure is associated with hyperammonemia and energetic changes in brain and peripheral organs. In animal models and in patients with mild HE, L-carnitine has been shown to be protective. In order to investigate the effect of L-carnitine on energy- and fatty acid metabolism, 1H- and 13C-NMR spectroscopy was used to measure metabolic pathways in brain and muscle following administration of [U-13C]glucose to rats with mild HE and in rats with ammonia-precipitated encephalopathy. Portacaval anastomosis in the rat resulted in a broad spectrum of neurobehavioral changes, such as a 80 impaired locomotor activity, which was largely prevented by L-carnitine. Concomitantly, L-carnitine improved mitochondrial energy metabolism and fatty acid catabolism in brain and muscle. In ammonia-precipitated encephalopathy, L-carnitine considerably delayed the time to coma of the rats, concomitantly to a prevention of ammonia-induced increased lactate synthesis in the brain. These results demonstrate that L-carnitine acts both in the brain and in the muscle by improvement of mitochondrial metabolism and fatty acid catabolism, which might explain L-carnitine’s therapeutic benefit in the prevention of mild HE and ammonia-precipitated encephalopathy in cirrhotic patients.

Details

show
hide
Language(s):
 Dates: 2007-05
 Publication Status: Published in print
 Pages: -
 Publishing info: -
 Table of Contents: -
 Rev. Type: -
 Identifiers: BibTex Citekey: ZwingmannGWBL2007
 Degree: -

Event

show
hide
Title: 2007 Joint Annual Meeting ISMRM-ESMRMB
Place of Event: Berlin, Germany
Start-/End Date: 2007-05-19 - 2007-05-25

Legal Case

show

Project information

show

Source 1

show
hide
Title: 2007 Joint Annual Meeting ISMRM-ESMRMB
Source Genre: Proceedings
 Creator(s):
Affiliations:
Publ. Info: -
Pages: - Volume / Issue: - Sequence Number: 2425 Start / End Page: 475 Identifier: -